newsfilter
← Latest News
GlobeNewswire·

Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics

TAMPA, Fla. and LONDON, July 21, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splicing modulator payloads,